Presbyopia Clinical Trials

Find Presbyopia Clinical Trials Near You

Refractive Accuracy of Argos in Conjunction With the Alcon Vision Suite Following Implantation of Presbyopia Correcting IOLs

Status: Completed
Location: See location...
Intervention Type: Device
Study Type: Observational
SUMMARY

The objective is to assess refractive accuracy of the Alcon Vision Suite (with Argos biometer) following Clareon PanOptix and AcrySof Vivity IOL implantation.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 50
Healthy Volunteers: t
View:

⁃ Subjects are eligible for the study if they meet the following criteria:

⁃ Note: Ocular criteria must be met in both eyes.

• Age-related cataract surgery (or RLE) patients that select Clareon PanOptix or AcrySof Vivity IOL.

• Gender: Males and Females.

• Age: 45 or older.

• Patients motivated to increase spectacle independence with relatively low incidence of visual phenomena.

• Willing and able to provide written informed consent for participation in the study.

• Willing and able to comply with scheduled visits and other study procedures.

• Have good ocular health, with no pathology that compromises visual acuity (outside of residual refractive error).

Locations
Other Locations
Canada
Valley Laser Eye Centre
Abbotsford British Columbia
Time Frame
Start Date: 2023-05-09
Completion Date: 2025-12-02
Participants
Target number of participants: 106
Related Therapeutic Areas
Sponsors
Leads: Valley Laser Eye Centre
Collaborators: Sengi

This content was sourced from clinicaltrials.gov